Skip to main content
Research project

S Crabb: Alliance with Plexxikon: A phase Ib/IIa trial to combine the CSF1 receptor inhibitor PLX3397 with the new generation AR antagonist enzalutamide in metastatic castration resistant prostate cancer


Lead researcher

Professor Simon Crabb PhD, BSc, MBBS, MRCP

Professor of Exp'tl Cancer Therapeutics

Research interests

  • Bladder cancer
  • Prostate cancer
  • Predictive biomarkers
Other researchers

Professor Gareth Griffiths

Director Clinical Trials Unit

Collaborating research institutes, centres and groups

Back to top